RAB10 and Parkinson disease: No differences in reduction of phosphorylation between PBMCs isolated from idiopathic PD patients or controls were observed for the Ser935 LRKK2 and the Thr73 Rab10 sites in ex vivo studies using nonselective LRRK2 inhibitors.20, 21